Literature DB >> 14872262

[Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

F Schirra1, K W Ruprecht.   

Abstract

Recent epidemiologic studies quote a prevalence of 5,2% to 63% for dry eye depending on definition. Many risk factors have been identified, among other things the female gender. Dry eye interferes significantly with quality of live. Measurement of the change in temperature and humidity during blinking turned out to be a reliable diagnostic tool. Videokeratoscopy explains well-known visual impairments related to dry eye and, along with lipid film interferometry, provides insight into tear film dynamics. The importance of tear film proteins is underestimated. Among therapeutics for symptomatic relief hyaluronic acid proved to be particularly useful but also the sequence of lid hygiene, warm compresses and lid massage is fundamentally important. The effectiveness of punctum plugs is ascribed considerably to a more efficient impact of essential tear film components. Topical cyclosporine A, INS365, 15(S)-HETE as well as topical androgens represent a whole new class of drugs for causal therapy of dry eye.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14872262     DOI: 10.1007/s00347-003-0958-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  77 in total

1.  Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye.

Authors:  S Shimmura; J Shimazaki; K Tsubota
Journal:  Cornea       Date:  1999-07       Impact factor: 2.651

2.  Tolerability and safety of two new preservative-free tear film substitutes.

Authors:  Sven Dinslage; Wilhelm Stoffel; Michael Diestelhorst; Günter K Krieglstein
Journal:  Cornea       Date:  2002-05       Impact factor: 2.651

3.  Economic and quality of life impact of dry eye symptoms in women with Sjögren's syndrome.

Authors:  R M Sullivan; J M Cermak; A S Papas; M R Dana; D A Sullivan
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

4.  Improved functional visual acuity after punctal occlusion in dry eye patients.

Authors:  Eiki Goto; Yukiko Yagi; Minako Kaido; Yukihiro Matsumoto; Kenji Konomi; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2003-05       Impact factor: 5.258

5.  Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells.

Authors:  Caroline Debbasch; Stéphanie Bruneau De La Salle; Françoise Brignole; Patrice Rat; Jean-Michel Warnet; Christophe Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-11       Impact factor: 4.799

6.  The clinical efficacy of silicone punctal plug therapy.

Authors:  Ming-Cheng Tai; C Banu Cosar; Elisabeth J Cohen; Christopher J Rapuano; Peter R Laibson
Journal:  Cornea       Date:  2002-03       Impact factor: 2.651

7.  Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.

Authors:  K S Kunert; A S Tisdale; M E Stern; J A Smith; I K Gipson
Journal:  Arch Ophthalmol       Date:  2000-11

Review 8.  Evaluation and differential diagnosis of keratoconjunctivitis sicca.

Authors:  M A Lemp
Journal:  J Rheumatol Suppl       Date:  2000-12

9.  INS365 suppresses loss of corneal epithelial integrity by secretion of mucin-like glycoprotein in a rabbit short-term dry eye model.

Authors:  Tsutomu Fujihara; Tadahiro Murakami; Takashi Nagano; Masatsugu Nakamura; Katsuhiko Nakata
Journal:  J Ocul Pharmacol Ther       Date:  2002-08       Impact factor: 2.671

Review 10.  Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia.

Authors:  A J Lee; J Lee; S-M Saw; G Gazzard; D Koh; D Widjaja; D T H Tan
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

View more
  5 in total

Review 1.  [Blinking activity during visual display terminal work. 2: reduced blinking and therapeutic approaches].

Authors:  F Ziemssen; N Freudenthaler; K Regnery; T Schlote
Journal:  Ophthalmologe       Date:  2005-09       Impact factor: 1.059

2.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

Review 3.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

Review 4.  [Ophthalmological complications in Sjögren's syndrome].

Authors:  C Jacobi; C Cursiefen
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

5.  [Dry eye symptoms following retinal surgery and ocular tumour therapy].

Authors:  H Heimann; R Gochman; M Hellmich; N E Bechrakis; M H Foerster
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.